Use of FK506 as primary or rescue therapy after liver transplantation in Hong Kong

Transplant Proc. 1998 Nov;30(7):3587-8. doi: 10.1016/s0041-1345(98)01147-6.

Authors

C M Lo¹, S T Fan, C L Liu, K L Chan, I O Ng, C L Lai, G K Lau, S K Fung, J Wong

Affiliation

¹ Department of Surgery, University of Hong Kong, Queen Mary Hospital, China.

PMID: 9838571
DOI: 10.1016/s0041-1345(98)01147-6

No abstract available

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Adult
Azathioprine / therapeutic use
Child
Cyclosporine / therapeutic use
Female
Follow-Up Studies
Graft Rejection / drug therapy*
Hong Kong
Humans
Immunosuppressive Agents / therapeutic use*
Liver Transplantation / immunology*
Liver Transplantation / mortality
Liver Transplantation / physiology
Male
Retrospective Studies
Survival Rate
Tacrolimus / therapeutic use*
Time Factors

Substances

Adrenal Cortex Hormones
Immunosuppressive Agents
Cyclosporine
Azathioprine
Tacrolimus